One Drop launches its diabetes tech in Canada after regulatory nod

One Drop announced today that its Bluetooth-enabled blood glucose monitoring system and mobile app are now available throughout Canada after landing approval from the country’s regulatory agency.

The company’s portfolio of diabetes management technology is now available in the U.S., Canada, the E.U. and the United Kingdom.

“In delivering the full One Drop experience to Canada, we are offering an essential extension to the Canadian healthcare system, just as we have in the US, EU, and UK,” founder & CEO Jeff Dachis said in prepared remarks. “You cannot improve health outcomes among people with chronic illness without continuous care. With on-demand advice from diabetes experts and data-driven insights served up every day, we’re delivering hyper-personalized care when and where it’s needed most.”

One Drop’s monthly platform includes a diabetes management mobile app, a glucose monitor and test strips, as well as a coaching service for people with diabetes.

The company sells its products using a direct-to-consumer subscription model. Users can subscribe to gain access to One Drop’s products starting at $19.95 per month, according to the company.

“Any diabetes ‘solution’ must drive positive clinical results,” Dachis added. “With One Drop, we are delivering a well-designed, evidence-based diabetes solution that is accessible, affordable, scalable, and effective to anyone, anywhere in the world. In doing so, we reach our goal of empowering everyone with diabetes to make better choices, lead fuller lives, and achieve meaningful improvements in their health.”

Want to stay on top of DDBN content? Sign up for our e-mail newsletter for a weekly dose of drug-device news.

Registration is Open for DeviceTalks Boston Registration is open for DeviceTalks Boston! Join us on June 5-6, 2019, as we explore the trends and technology that are shaping the future of the medical device industry. REGISTER NOW